Literature DB >> 25743864

Neuropsychiatric systemic lupus erythematosus: a diagnostic challenge.

Andrew Sommerlad1, John Duncan2, Michael P T Lunn3, Jacqueline Foong4.   

Abstract

A 58-year-old woman presented to neuropsychiatric services with increased frequency of confusional episodes and intermittent psychotic symptoms. She had a 19-year history of atypical epileptic seizures and cognitive decline. Detailed review of history and clinical investigations revealed that she had accumulated sufficient features to meet diagnostic criteria for systemic lupus erythematosus (SLE). She had previously had lymphopenia and a malar rash; she had positive antinuclear, anti-Ro (anti-Sjögren's-syndrome-related antigen A) and anti-SM (anti-Smith Antibody) antibodies, and elevated erythrocyte sedimentation rate. The seizures, cognitive impairment and psychosis were attributable to neuropsychiatric SLE. Treatment with immune-modulating therapy, cyclophosphamide, resulted in significant improvement in subjective and objective clinical presentation. Neuropsychiatric SLE should be considered a potential differential diagnosis for patients presenting with seizures, psychotic symptoms or cognitive decline. A detailed clinical evaluation with review of the medical history and appropriate laboratory analyses allows this diagnosis to be made, and appropriate treatment to be initiated. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25743864      PMCID: PMC4369033          DOI: 10.1136/bcr-2014-208215

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 2.  Factors influencing cognitive function, sleep, and quality of life in individuals with systemic lupus erythematosus: a review of the literature.

Authors:  Jerry J Sweet; Nicholas A Doninger; Phyllis C Zee; Lynne I Wagner
Journal:  Clin Neuropsychol       Date:  2004-02       Impact factor: 3.535

Review 3.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

4.  Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.

Authors:  L Barile-Fabris; R Ariza-Andraca; L Olguín-Ortega; L J Jara; A Fraga-Mouret; J M Miranda-Limón; J Fuentes de la Mata; P Clark; F Vargas; J Alocer-Varela
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 5.  [Systemic lupus erythematosus presenting with recurrent psychiatric disturbances].

Authors:  C Simonin; D Devos; J de Seze; P Charpentier; G Vaiva; M Goudemand; S Dubucquoi; E Hachulla; A Destée; L Defebvre
Journal:  Rev Neurol (Paris)       Date:  2004-09       Impact factor: 2.607

6.  Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.

Authors:  J Mikdashi; B Handwerger
Journal:  Rheumatology (Oxford)       Date:  2004-09-01       Impact factor: 7.580

7.  Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.

Authors:  Michelle Petri; Mohammad Naqibuddin; Kathryn A Carson; Daniel J Wallace; Michael H Weisman; Stephen L Holliday; Margaret Sampedro; Shalini Narayana; Peter T Fox; Crystal Franklin; Patricia A Padilla; Robin L Brey
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

Review 8.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

9.  Prevalence of cognitive impairment in systemic lupus erythematosus.

Authors:  R M Carbotte; S D Denburg; J A Denburg
Journal:  J Nerv Ment Dis       Date:  1986-06       Impact factor: 2.254

10.  Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients.

Authors:  Eleni I Kampylafka; Haralampos Alexopoulos; Michalis L Kosmidis; Demosthenes B Panagiotakos; Panayiotis G Vlachoyiannopoulos; Marinos C Dalakas; Haralampos M Moutsopoulos; Athanasios G Tzioufas
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

View more
  3 in total

1.  Neuropsychiatric Systemic Lupus Erythematosus: A Diagnostic Conundrum.

Authors:  Vivek Joseph; Rahul Anil; Sary Aristy
Journal:  J Clin Med Res       Date:  2016-08-30

Review 2.  Psycho-rheumatic Integration in Systemic Lupus Erythematosus: An Insight into Antibodies Causing Neuropsychiatric Changes.

Authors:  Gouthami Nalakonda; Mimsa Islam; Vera E Chukwu; Ahmad Soliman; Rujina Munim; Inas Abukraa
Journal:  Cureus       Date:  2018-08-03

3.  Acute psychosis as the presenting manifestation of lupus.

Authors:  Piyush Kumar; Abhishek Kumar; Vikram Thakur; Chandra B Sharma; Aneesha Thomas; Subhankar Chatterjee
Journal:  J Family Med Prim Care       Date:  2021-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.